The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Price to Book AnalysisPrice to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is accounting value of assets minus liabilities.
About Price to BookPrice to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
|Compare to competition|
Based on latest financial disclosure the price to book indicator of VanEck Vectors Biotech ETF is roughly 2.74 times. This is 211.36% higher than that of the Van Eck family, and about the same as Health (which currently averages 2.76) category, The Price to Book for all etfs is 182.47% lower than the firm.
VanEck Vectors Biotech Fundamental Drivers Relationships
VanEck Vectors Biotech ETF is fourth largest ETF in price to earning as compared to similar ETFs. It is third largest ETF in price to sales as compared to similar ETFs fabricating about 0.27 of Price to Sales per Price to Earning. The ratio of Price to Earning to Price to Sales for VanEck Vectors Biotech ETF is roughly 3.74